PREDICTION TO PATIENT
AI finds the opportunity Biology decides
01
Map the disease
Genetics, molecular pathways, clinical phenotypes and unmet need
02
Prioritise compounds
Our preclinical platforms rank opportunities by rationale, feasibility and development risk
03
Validate experimentally
Cellular and in vivo platforms test efficacy, exposure and biomarkers
04
Build the package
Reproducible data supports licensing, acquisition or co-development
GeN closed loop
Predict → Prioritise → Validate → Refine → Advance
